{
    "Trade/Device Name(s)": [
        "QIAstat-Dx GI Panel 2 Mini B&V"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K243813",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220062"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH"
    ],
    "Summary Letter Date": "January 8, 2025",
    "Summary Letter Received Date": "December 11, 2024",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Norovirus",
        "Campylobacter",
        "Shigella",
        "Shiga-like toxin Escherichia coli (STEC)",
        "Salmonella"
    ],
    "Specimen Type(s)": [
        "Preserved stool"
    ],
    "Specimen Container(s)": [
        "Para-Pak C&S",
        "FecalSwab"
    ],
    "Instrument(s)/Platform(s)": [
        "QIAstat-Dx Analyzer 1.0"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time RT-PCR",
        "Nucleic acid extraction",
        "Fluorescence-based detection"
    ],
    "Methodologies": [
        "PCR",
        "Nucleic acid amplification",
        "Multiplex detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Reagent",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for QIAstat-Dx GI Panel 2 Mini B&V multiplex nucleic acid assay for detecting Norovirus and selected bacteria in stool using QIAstat-Dx Analyzer 1.0",
    "Indications for Use Summary": "Aid in the qualitative detection and identification of nucleic acids from multiple bacteria and Norovirus directly from preserved stool samples for diagnosis of gastrointestinal infection, used with QIAstat-Dx Analyzer 1.0 and in conjunction with other diagnostic data.",
    "fda_folder": "Microbiology"
}